Catalyze: Product Definition for Small Molecules, Biologics and Combination Products - Target Identification and Validation, and Preliminary Product/Lead Series Identification (R61/R33 Clinical Trials Not Allowed)
Department of Health and Human Services
The goal of the NHLBI Catalyze Program is to provide a comprehensive suite of support and services to facilitate the transition of basic science discoveries into viable diagnostic and therapeutic candidates that have been cleared for human testing, and to develop translational researchers fluent in product development and entrepreneurship. This specific Catalyze Product Definition initiative will provide the early stage translational supportneeded for the activities required to identify and characterize potential therapeutic candidates and combination products to treat HLBS diseases and disorders. This initiative has a companion initiative that supports development of devices and diagnostics
Funding
Award size
Not specified
Type
Grant
Dates
Deadline
Later
Posted
11/22/2024
Closes
2027-12-23
Eligibility
Eligibility
Nonprofits having a 501(c)(3) status with the IRS, other than institutions of higher educationSmall businessesCity or township governmentsIndependent school districtsNative American tribal governments (Federally recognized)Special district governmentsNonprofits that do not have a 501(c)(3) status with the IRS, other than institutions of higher educationPublic and State controlled institutions of higher educationNative American tribal organizations (other than Federally recognized tribal governments)Public housing authorities/Indian housing authoritiesFor profit organizations other than small businessesCounty governmentsState governmentsOthers (see text field entitled "Additional Information on Eligibility" for clarification)Private institutions of higher education
Program
Funding area
Health - HL
Opportunity #
RFA-HL-26-017
Source
Status
Open
Market
Government
Level
Federal
Source
Grants.gov